Genentech to shut down cancer immunology department amid broader R&D rethink

Genentech to shut down cancer immunology department amid broader R&D rethink

Source: 
Fierce Biotech
snippet: 

Genentech will close its cancer immunology department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months.